Found 37 matching trials
A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar
PHASE2This research study is testing whether a weekly medication called tirzepati...
Location
Institut de Recherches Cliniques de Montréal
Testing a Conversion Factor for a More Rapidly Acting Insulin in an Automated Insulin Delivery System Among Adolescents With T1D
NAA randomized controlled trial of Control-IQ, assessing glycemic control (ti...
Location
University of Virginia Center for Diabetes Technology
Diabetes Assistant (DiAs) Control-to-Range (CTR) Nocturnal Closed-Loop Camp Study
NAThe primary goal is to test the function of the Diabetes Assistant (DiAs) e...
Location
Stanford University
A Pilot Test of t:Slim X2 With Control-IQ Technology
NAA 36-48 hour admission testing the t:slim X2 with Control-IQ Technology...
Location
University of Virginia Center for Diabetes Technology
Adaptive Biobehavioral Control (ABC) of Automated Insulin Delivery
NAThe purpose of this pilot study is to test the safety and feasibility of us...
Location
University of Virginia Center for Diabetes Technology
Safety of Artificial Pancreas Therapy in Preschoolers, Age 2-6
NAA single-arm, multi-center, clinical study to assess the safety profile of ...
Location
Stanford University
The Pediatric Artificial Pancreas Automated Initialization Trial
NAThe goal of this clinical trial is to obtain safety data and exploratory gl...
Location
Stanford University
Maximising Time With a Normal Blood Glucose to Restore the Glucagon Response in Type 1 Diabetes
NAAlmost all people who have had type 1 diabetes for 5 years have a defect in...
Location
Edinburgh Royal Infirmary/University of Edinburgh
The VRIF Trial: Hypoglycemia Reduction With Automated-Insulin Delivery System
NAThe objective of this pilot study is (i) to test the use of an Artificial P...
Location
University of Virginia
The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas (DCLP3 Extension)
NAThis is a 3-month extension study (DCLP3 Extension) following a primary tri...
Location
Sansum Diabetes Research Institute